Sparian Biosciences
UEI: E6GKXJ7MWV68
• CAGE: 8EU60
• DBA: PALION THERAPEUTICS
Overview
Awardee Type
Parent
Company Description
Sparian Biosciences is a bio-pharmaceutical company focusing on discovering and developing new therapies to target the central nervous system (CNS).
Name
Sparian Biosciences
Headquarters
New York, NY
United States
United States
Most Recent Award
Sept. 30, 2024
Calculating
Federal grant recipient
SPARIAN BIOSCIENCES INC
dba PALION THERAPEUTICS
(UEI E6GKXJ7MWV68, CAGE 8EU60)
is headquartered in New York NY.
Its primary registered NAICS is 541714 Research and Development in Biotechnology (except Nanobiotechnology).
The corporation
was founded in September 2017 and
federally registered in
September 2019.
Federal Award Analysis
Sparian Biosciences federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
SPARIAN BIOSCIENCES INC
DBA
PALION THERAPEUTICS
UEI
E6GKXJ7MWV68
CAGE Code
8EU60
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Sept. 13, 2017
Initial Registration
Sept. 10, 2019
Last Registration
Jan. 7, 2025
Registration Activation
Jan. 7, 2025
Registration Expiration
Jan. 5, 2026
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
<500
Accepts Credit Cards
No
People
Vendor contacts at Sparian Biosciences
Grant Awards
Sparian Biosciences direct grants
Subgrant Awards
Sparian Biosciences subgrant awards
Teaming Partners
Disclosed awardee sub and prime contract and grant relationships
Sparian Biosciences